How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

690 results for

Dysuria in Children

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

541. Tuberculosis (Diagnosis)

to coma over a period of days to weeks Low-grade or absent fever Symptoms of skeletal TB may include the following: Back pain or stiffness Lower-extremity paralysis, in as many as half of patients with undiagnosed Tuberculous arthritis, usually involving only 1 joint (most often the hip or knee, followed by the ankle, elbow, wrist, and shoulder) Symptoms of genitourinary TB may include the following: Flank pain Dysuria Frequent urination In men, a painful scrotal mass, prostatitis, orchitis (...) considerations for drug therapy in children include the following: Most children with TB can be treated with isoniazid and rifampin for 6 months, along with pyrazinamide for the first 2 months if the culture from the source case is fully susceptible. For postnatal TB, the treatment duration may be increased to 9 or 12 months Ethambutol is often avoided in young children Special considerations for drug therapy in HIV-infected patients include the following: Dose adjustments may be necessary [ , ] Rifampin

2014 eMedicine Emergency Medicine

542. Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery

as catheter discontinuation with inability to void 6 hours post-removal, or void with post-void residual greater than 200 cc of urine. Secondary Outcome Measures : Number of Participants With a Symptomatic Urinary Tract Infection [ Time Frame: During 1 week of hospitalization (prior to discharge) ] Urinary tract infection defined as symptomatic urinary complaints such as dysuria, with urinalysis consistent with infection. Eligibility Criteria Go to Information from the National Library of Medicine (...) to freely give written informed consent to participate in the study and have signed the Informed Consent Form; Males or females, >18 years of age inclusive at the time of study screening; American Society of Anesthesiologists (ASA) Class I-III; Infraperitoneal colorectal surgery (open and/or laparoscopic); Elective Surgery Exclusion Criteria: Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures; Children <18; No perioperative antibiotics; Past

2013 Clinical Trials

543. Cranberry on Urinary Tract Infections

containing control formulation Drug: Placebo Outcome Measures Go to Primary Outcome Measures : Number of urinary tract infections [ Time Frame: 12 months ] The number of symptomatic UTIs over 12 months (defined by self-report as having one or more of the following symptoms: dysuria, frequency, urgency, hematuria, supra-pubic pressure or fever), the proportion of participants with at least 1 symptomatic UTI, the median time to the first UTI Secondary Outcome Measures : Side effects [ Time Frame: 12 months (...) ] Eligibility Criteria Go to Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: Child, Adult, Older Adult Sexes Eligible for Study: Female

2013 Clinical Trials

544. Ibuprofen Versus Mecillinam for Uncomplicated Cystitis

Criteria Inclusion Criteria: woman between 18 and 60 years of age dysuria and pollakiuria and/or urinary urgency ability to give written consent Exclusion Criteria: pregnancy/breastfeeding child under one month of age diabetes kidney disease organic aciduria clinical suspicion of pyelonephritis; fever, reduced general condition, upper back pain vaginal symptoms such as discharge or irritation severe abdominal pain symptoms that have lasted for more than seven days one or more urinary tract infections (...) symptom load with regard to specific symptoms and when feeling completely symptom free will be registered in the patient diary. Secondary Outcome Measures : The patients' symptom load with regard to specific symptoms. [ Time Frame: Seven days ] Specific symptoms, such as dysuria, urgency and pollakiuria, will be given a number from 0-6 in the patient diary, 0 = no problem and 6= as bad as it can get. Other Outcome Measures: Proportion of patients who were in need of a secondary medical consult within

2013 Clinical Trials

545. Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment

schedule. In the first days following C-HT, storage LUTS (frequency, dysuria, urgency, nocturia) (25.6%) and hematuria (6.0%) are the most common adverse events. Most studies mention that these symptoms were mild and transient, resolving spontaneously within a few days of treatment. One study described severe cystitis complaints in three patients (16%), but other studies have not confirmed these adverse events. Two studies report the development of a contracted bladder and severe urinary incontinence (...) and no evidence of disease at cystoscopic evaluation Criteria Inclusion Criteria: both genders age above 18 bladder cancer patients after completion of Synergo treatment no evidence of disease at cystoscopic evaluation after completion of Synergo treatment Exclusion Criteria: children pregnant women failure to complete Synergo treatment evidence of bladder cancer at cystoscopic evaluation after Synergo treatment Contacts and Locations Go to Information from the National Library of Medicine To learn more about

2013 Clinical Trials

546. Contraceptive discontinuation and switching among couples receiving integrated HIV and family planning services in Lusaka, Zambia. Full Text available with Trip Pro

was associated with the women's younger age, desire for more children within the next year, heavy menstrual bleeding, bleeding between periods and cystitis/dysuria. Health concerns among women about contraceptive implants and male partners not wanting more children were associated with upgrading from oral contraceptives or condoms. HIV status of the woman or the couple was not predictive of switching or stopping.We found complicated patterns of contraceptive use. The predictors of contraception switching

2013 AIDS Controlled trial quality: uncertain

547. Parental evaluation of postoperative outcome of circumcision with Plastibell or conventional dissection by dorsal slit technique: A randomized controlled trial. (Abstract)

children (p < 0.0001). Postoperatively, children in the PD group required 2.79 fold more analgesic than those in the CDS group. 97.9% of parents in the PD group and 80.2% of parents in the CDS group claimed satisfactory aesthetic results. The PD group parents were statistically significantly more concerned about swelling.Plastibell use has comparable outcomes to the conventional dissection technique for paediatric circumcision and has an obvious advantage of shorter surgical duration. However (...) Parental evaluation of postoperative outcome of circumcision with Plastibell or conventional dissection by dorsal slit technique: A randomized controlled trial. To evaluate and compare parental satisfaction after Plastibell and conventional dissection circumcision.198 children were randomly and equally allocated to two groups (PD: Plastibell and CDS: dissection) for circumcision. Follow-up was done at 7th, 15th and 90th day after surgery. Written questionnaires were given to parents at the time

2013 Journal of pediatric urology Controlled trial quality: uncertain

548. Articles of the month (February 2016)

of disease in childhood. 98(1):27-9. 2013. PMID: Here is a contribution from Dr. Kate Bingham. You probably know how I feel about getting urines in pediatric patients. ( ) However, for newborns, a urine culture is going to get done. This paper describes a technique to get the urine without a foley. Basically, feed kid, wait 25 min, clean genitals, hold baby under armpits (standing position), tap suprapubic area at 100/min for 30 seconds, then massage low back for 30 seconds. Repeat until pee is produced (...) outcome. There weren’t any differences in the secondary outcomes, such as admission to hospital, length of stay, or return visits. Bottom line: Once again, dex is great for asthma Sticking with obvious pediatric topics: ondansetron works Danewa AS, Shah D, Batra P, Bhattacharya SK, Gupta P. Oral Ondansetron in Management of Dehydrating Diarrhea with Vomiting in Children Aged 3 Months to 5 Years: A Randomized Controlled Trial. The Journal of pediatrics. 169:105-109.e3. 2016. PMID: This is another paper

2016 First10EM

549. How to create a modern superhero

How to create a modern superhero How to create a modern superhero How to create a modern superhero | | September 23, 2016 168 Shares You start out by working in a busy emergency department. You see patients with all sorts of complaints: abdominal pain, headaches, and chest pain. Vomiting, diarrhea, and dysuria. Ankle sprains, bug bites, and allergic reactions. Domestic violence, rape, and child abuse. You don’t ever let the stress of the job take away your humanity. You treat your patients (...) have him treat abused patients during the day, and then go after the psychopaths who hurt them at night: the wife beaters, rapists, and child molesters. You make him cunning enough to be able to gather information during his shift, and use that information at night to target the psychopaths. You add depth to this character, place him in a city where you used to work, and add a love story. Soon you realize that one page has led to two hundred. You send it to friends for review, find a professional

2016 KevinMD blog

550. Postrenal Failure

Postrenal Failure Postrenal Failure Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Postrenal Failure Postrenal Failure Aka: Postrenal (...) that results in dilatation of the renal pelvis and calyces. It is caused by obstruction of urine flow, nephrolithiasis, or vesicoureteral reflux. Signs and symptoms include flank pain, nausea, vomiting, fever, and dysuria. Definition (NCI_NCI-GLOSS) Abnormal enlargement of a kidney, which may be caused by blockage of the ureter (such as by a kidney stone) or chronic kidney disease that prevents urine from draining into the bladder. Definition (CSP) distention of the pelvis and calices of the kidney

2015 FP Notebook

551. Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus Vulvar Lichen Sclerosus Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Vulvar Lichen Sclerosus Vulvar Lichen (...) subepithelial fibrosis. Clinical manifestations include pruritus, dysuria, and dyspareunia. Definition (MSH) Atrophy and shriveling of the SKIN of the VULVA that is characterized by the whitish LICHEN SCLEROSUS appearance, inflammation, and PRURITUS. Concepts Disease or Syndrome ( T047 ) MSH ICD10 SnomedCT 73057003 , 156019006 , 198379009 , 266666006 , 26348009 , 198380007 English Vulvae, Kraurosis , Leukoplakic vulvitis , VULVAL LEUKOPLAKIA , kraurosis of vulva (diagnosis) , kraurosis of vulva

2015 FP Notebook

552. Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

is based on 24 hour periods from the first dose date and time. ] Number of patients with symptomatic resolution (or return to premorbid state) of UTI-specific symptoms except flank pain (frequency/urgency/dysuria/suprapubic pain) with resolution of or improvement in flank pain based on the patient-reported symptom assessment response at the Day 5 visit in the mMITT analysis set. The sponsor will conclude noninferiority if the lower limit of the 95% CI of difference (corresponding to a 97.5% 1-sided (...) ) of all UTI-specific symptoms (frequency/urgency/dysuria/suprapubic pain/flank pain) based on the patient-reported symptom assessment response at the TOC visit in the mMITT analysis set. The sponsor will conclude noninferiority if the lower limit of the 95% CI of difference (corresponding to a 97.5% 1-sided lower bound) is greater than -12.5% for both FDA coprimary outcome variables (symptomatic resolution at day 5 or favorable combined response at test of cure (TOC)). Per-patient Microbiological

2012 Clinical Trials

553. Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)

of the clinical deterioration) Myocardial infarction death from any cause Minor safety outcome [ Time Frame: From date of randomization until the date of first documented intracranial hemorrhage on follow-up MRI, or date of first documented side effects, whichever came first, assessed up to 3 months ] Intracranial hemorrhage on follow-up MRI Side effects including headache, arrhythmia, chest pain, dysuria, or gastrointestinal hemorrhage Eligibility Criteria Go to Information from the National Library (...) of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: Child, Adult, Older Adult Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Patients

2012 Clinical Trials

554. Botulinum Toxin Urethral Sphincter Injection for Dysfunctional Voiding

: Adults with age of 20 years old or above. Free of active urinary tract infection. Free of bladder outlet obstruction on enrollment. Patients should have severe dysuria or urinary retention, large residual urine and have been treated with medication or other therapeutic modality for over 3 months. Exclusion Criteria: Patients with severe cardiopulmonary disease and such as congestive heart failure, arrhythmia, poorly controlled hypertension, not able to receive regular follow-up. Patients with bladder (...) is pregnant, lactating, or with child-bearing potential without contraception. Patients with any other serious disease considered by the investigator not suitable for general anesthesia or in the condition to enter the trial. Patients participated investigational drug trial within 1 month before entering this study. Written informed consent has been obtained. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact

2012 Clinical Trials

555. Efficacy of Extracorporal Shock Wave Therapy in Patient With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain Syndrome

could be due to endometrioses, ovarian cyst, colitis, etc, making the correct diagnosis important (1-3). The most prevalent reason for CPP in men is non-bacterial chronic prostatitis and in many cases they are considered equivalent to each other (4). Chronic non-bacterial prostatitis is associated with pain in pelvic region and could be associated with other symptoms such as dysuria, myalgia, arthralgia, chronic fatigue, burning sensation in the urethra, abdominal, urine frequency, and pain after (...) Layout table for investigator information Principal Investigator: Farshid Alizadeh, pediatric urologist Isfahan University of Medical Sciense More Information Go to Layout table for additonal information Responsible Party: Farshid Alizadeh, pediatric urologist, Isfahan University of Medical Sciences ClinicalTrials.gov Identifier: Other Study ID Numbers: IsfahanUMS1 First Posted: October 26, 2012 Last Update Posted: October 26, 2012 Last Verified: October 2012 Additional relevant MeSH terms: Layout

2012 Clinical Trials

556. Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis

in childhood. Any prior treatment with anti-epileptic medications specifically prescribed for the treatment of epilepsy. Onset of MS exacerbation within the 60 days prior to the Screening Visit. Use of mitoxantrone, cyclophosphamide, rituximab, alemtuzumab, daclizumab, cladribine or any other immune suppressant (except FTY720) or antibody (except natalizumab) within 3 months prior to the Screening Visit, or scheduled use during study participation. Pulsed steroid treatment within the 60 days prior (...) of drugs under study, e.g. known allergy to pyridine-containing substances. Any prior treatment with fampridine (4-aminopyridine; 4 AP) or 3,4-diaminopyridine in any formulation. Patients with an acute urinary tract infection at the Screening Visit as indicated by symptoms like painful urination/dysuria, urinary frequency, urinary urgency, pollakiuria, suprapubic pain, flank pain, costovertebral angle tenderness or fever >38°C in combination with a clinically significant pathological finding

2012 Clinical Trials

557. Compare Ceftazidime-Avibactam and Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)

is based on 24 hour periods from the first dose date and time. ] Number of patients with symptomatic resolution (or return to premorbid state) of UTI-specific symptoms except flank pain (frequency/urgency/dysuria/suprapubic pain) with resolution of or improvement in flank pain based on the patient-reported symptom assessment response at the Day 5 visit in the mMITT analysis set. The sponsor will conclude noninferiority if the lower limit of the 95% CI of difference (corresponding to a 97.5% 1-sided (...) ) of all UTI-specific symptoms (frequency/urgency/dysuria/suprapubic pain/flank pain) based on the patient-reported symptom assessment response at the TOC visit in the mMITT analysis set. The sponsor will conclude noninferiority if the lower limit of the 95% CI of difference (corresponding to a 97.5% 1-sided lower bound) is greater than -12.5% for both FDA coprimary outcome variables (symptomatic resolution at day 5 or favorable combined response at test of cure (TOC)). Per-patient Microbiological

2012 Clinical Trials

558. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age. (Abstract)

specific investigation into the symptoms they experience. We identified that patients diagnosed with interstitial cystitis and painful bladder syndrome have variable clinical symptom profiles depending on the age at the time of their diagnosis. Dyspareunia, external genitalia pain, urgency, frequency and dysuria were more common in younger patients whereas nocturia, urinary incontinence and the presence of Hunner's ulcers were more common in older patients. Better defining symptom profiles for patients (...) at the time of evaluation may potentially aid in more accurate and expedited diagnosis of these conditions, particularly in the youngest patient population which is being recognized more commonly in recent times.• To investigate the clinical profile differences among patients with interstitial cystitis/painful bladder syndrome (IC/PBS) based upon age at the time of diagnosis from childhood into the geriatric age group.• An analysis of 268 patients with IC/PBS seen between 1990 and 2008 was performed

2012 BJU international

559. Inflammatory Myofibroblastic Tumor of the Bladder in a 10-Year-old Girl. (Abstract)

Inflammatory Myofibroblastic Tumor of the Bladder in a 10-Year-old Girl. Inflammatory myofibroblastic tumors (IMTs) of the bladder are rarely encountered bladder tumors during the pediatric age. The unknown malignant potential of these tumors causes controversy for their treatment and follow-up. We report a 10-year-old girl who was referred to our clinic with dysuria and enuresis. The clinicopathological evaluation was compatible with IMT and a bladder preserving approach was used

2012 Urology

560. Posterior urethral valves diagnosed by bedside ultrasound in the ED. (Abstract)

Posterior urethral valves diagnosed by bedside ultrasound in the ED. Posterior urethral valves are the most common cause of urinary obstruction in male children. Presentations of posterior urethral valves beyond the neonatal period include urinary tract infection, abdominal mass, renal failure,diminished urinary stream, crying during micturition,incontinence, dysuria, hematuria, or failure to thrive. Early diagnosis is imperative because early surgical relief of the obstruction is believed (...) to help prevent the progression to endstage renal disease.This case serves to remind us that, in the male child who presents with urinary symptoms and/or abdominal symptoms,the bedside sonogram is a valuable tool that can clarify the diagnosis and expedite care.

2012 American Journal of Emergency Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>